Lack of FDA resources extends clinical hold on ALS drug NUZ-001
Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS drug NUZ-001.| ALS News Today
Due to a lack of resources and personnel, the FDA has delayed until October its decision on lifting a clinical hold on ALS drug NUZ-001.| ALS News Today
Various adaptations and equipment are available that can help a person with ALS eat, dress, use the bathroom, and move around.| ALS News Today
No description.| ALS News Today
No description.| ALS News Today
An ALS diagnosis requires testing for signs of the neurodegenerative disease that rules out other disorders with similar symptoms.| ALS News Today
Lindsey Shapiro is a science writer for ALS News Today with a PhD in neuroscience. She covers the latest news and information on a variety of amyotrophic lateral sclerosis topics.| ALS News Today
ALS is a neurodegenerative condition that causes muscle weakness, movement problems, and breathing issues. Learn more about ALS symptoms here.| ALS News Today
Category archive page for News.| ALS News Today
ALS is a progressive neurological disorder that damages motor neurons. Learn more about types, causes, symptoms, diagnosis, and treatment.| ALS News Today
